Independence Bank of Kentucky Boosts Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Independence Bank of Kentucky grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,018 shares of the company’s stock after buying an additional 114 shares during the period. Independence Bank of Kentucky’s holdings in GE HealthCare Technologies were worth $158,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. LGT Financial Advisors LLC raised its stake in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the last quarter. Capital Performance Advisors LLP acquired a new position in shares of GE HealthCare Technologies in the third quarter valued at approximately $26,000. Ashton Thomas Securities LLC acquired a new stake in GE HealthCare Technologies during the third quarter worth approximately $26,000. Darwin Wealth Management LLC purchased a new stake in GE HealthCare Technologies in the 3rd quarter worth approximately $31,000. Finally, Continuum Advisory LLC lifted its stake in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock worth $31,000 after purchasing an additional 168 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Trading Down 1.4 %

GEHC opened at $88.30 on Monday. The firm’s 50 day moving average is $82.87 and its 200-day moving average is $85.04. GE HealthCare Technologies Inc. has a 52-week low of $72.52 and a 52-week high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm has a market capitalization of $40.34 billion, a P/E ratio of 24.26, a P/E/G ratio of 2.90 and a beta of 1.11.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a $0.035 dividend. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

Wall Street Analysts Forecast Growth

GEHC has been the subject of several analyst reports. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $96.00.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.